Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Efficacy and safety of LX9211 for relief of diabetic peripheral neuropathic pain (RELIEF-DPN 1): results of a double-blind, randomized, placebo-controlled, proof-of-concept study
Retatrutide weight loss from Phase 2 and TRIUMPH-4 Retatrutide entered the clinical picture with a Phase 2 trial published in the New England Journal of Medicine
Can I combine creatine with GLP-1 medication
The best peptide vendors guide helps identify reputable sources, though no research peptide supplier can match pharmaceutical grade manufacturing standards
Report Coverage This research report categorizes the market for South Africa diabetes drugs based on various segments and regions forecasts revenue growth and analyses trends in each submarket